Show
Sort by
-
Non-cytotoxic crosslinkers for heart valve tissue engineering
-
Twenty years' single-center experience with mechanical heart valves : a critical review of anticoagulation policy
-
Bioactive porcine matrices in heart valve tissue engineering
-
Fifteen years' single-center experience with the ATS bileaflet valve
-
Long-term results with a stentless porcine aortic valve: the Edwards PRIMA model 2500
-
Genipin Blues: an alternative non-toxic crosslinker for heart valves?
-
Histological evaluation of autophagic cell death in calcified aortic valve stenosis
-
Predicting ATS Open Pivot (TM) heart valve performance with computational fluid dynamics
-
Transforming growth factor-beta-induced transition of fibroblasts: A model for myofibroblast procurement in tissue valve engineering
-
Lower-intensity anticoagulation for mechanical heart valves: A new concept with the ATS bileaflet aortic valve